Van Eck Associates Corp Bristol Myers Squibb CO Transaction History
Van Eck Associates Corp
- $77.4 Billion
- Q1 2025
A detailed history of Van Eck Associates Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Van Eck Associates Corp holds 4,993,118 shares of BMY stock, worth $237 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
4,993,118
Previous 9,069,826
44.95%
Holding current value
$237 Million
Previous $513 Million
40.64%
% of portfolio
0.39%
Previous 0.66%
Shares
32 transactions
Others Institutions Holding BMY
# of Institutions
2,738Shares Held
1.59BCall Options Held
25.8MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.09 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.54 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.13 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.51 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.16 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $101B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...